medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2016, Number 3

<< Back Next >>

Arch Neurocien 2016; 21 (3)

Use of tranexamic acid for prevention of coagulopathy during resection of brain tumor

Tejada JH, Rivas CV, Charry D

Language: Spanish
References: 15
Page: 29-33
PDF size: 602.78 Kb.


ABSTRACT

Tranexamic acid (TXA) is a medication to priphylaxis use and excessive blood lost treat. As a consequience of CRASH 2 publishing earned itself an important área in the bleeding lost perioperative surgery field. A patient of 39 years old eith a big supratentorial tumor was taken to embolization without successful, using tranexamic acid such a bledding treatment clinic case.


REFERENCES

  1. Deogaonkar A, De Georgia M, Mascha E, Todd M, Schubert A, IHAST Investigators. Intraoperative blood loss is associated with worse outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2006;18:302.

  2. Central Brain Tumor Registry of the United States. Available at http:// www.cbtrus.org. http://www.cbtrus.org/reports//2007-2008/2007report. pdf, last consulted Sept 14th, 2009.

  3. Hou J, Kshettry VR, Selman WR. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus 2013;35(6):E2.

  4. Simis A, Pires de Aguiar PH, Leite CC. Peritu- moral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol 2008;70(5): 471–7.

  5. Vignes JR, Sesay M, Rezajooi K, et al. Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 2008;15(7):764–8.

  6. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: Benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004;70:15-28.

  7. Murray DJ, Pennell BJ, Weinstein SL, Olson JD. Packed red cells in acute blood loss: Dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995;80:336-42.

  8. Erstad BL. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 2001;35:925-34.

  9. Manucci PM. Hemostatic drugs. N Engl J Med 1998; 339: 245-53.

  10. Dunn CJ, Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999;57:1005-32.

  11. Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: A systematic review and meta-analysis. Eur J Cardiothorac Surg 2012;42:781-6.

  12. Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: A prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976) 2008;33:2577-80.

  13. White N, Bayliss S, Moore D. Systematic review of interventions for minimizing perioperative blood transfusion for surgery for cra- niosynostosis. J Craniofac Surg 2015;26:26–36.

  14. Ramya Vel, Bidkar Prasanna Udupi, Munaganuri Venkata, Siva Satya Prakash, Sethuramachandran Adinarayanan, Sandeep Mishra, et al. Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients. Saudi J Anaesth 2015 ; 9(1): 42–8.

  15. Novikov VIu, Kondrat’ev AN, Driagina NV, Nazarov RV. Using of tranexamic acid (Tranexam) for prevention and correction of coagulopathy during brain tumors removal. Anesteziol Reanimatol 2011 ;(4):61-6.




2020     |     www.medigraphic.com